Postmenopausal women are much more likely than premenopausal women...
Category:
Health
Latest
India reports first H3N2 deaths, one each from K’taka, Haryana; seasonal influenza cases likely to decline from March-end: Govt
''Young children and old age persons with comorbidities are the...
Brain stroke is the second most common cause of death in India:top health expert
Delivering a keynote address at the event titled, "Stroke care and...
2nd study testing a COVID-19 antibody drug has a setback
Earlier this month, a different group of monitors recommended pausing enrollment in a U.S. National Institutes of Health study testing an Eli Lilly antibody drug to investigate a possible safety issue in hospitalized patients.
COVID-19 caseload in India breaches 80-lakh mark with 49,881 new cases
The world’s second most populous nation also has the second highest tally of infections after the United States, which has recorded 8.8 million
The COVID-19 case fatality rate has further declined to 1.49 per cent.
There are 603687 active cases of coronavirus infection in the country which comprises 7.5 per cent of the total caseload, the data stated.
Fare limits to remain in place for another three months Puri
“Even though we are extending it by three months, if by the time we reach the end of the year, and if we find that there is a very appreciable movement in the situation and we are reaching pre-COVID levels, I would absolutely have no hesitation if my colleagues (aviation ministry officials) want us to not utilise the price band for the full three months period,” Puri added.
Under pressure, WHO plans COVID-19 vaccine insurance scheme for poor nations
The scheme is being set up by the promoters of the COVAX vaccine facility, which is co-led by the WHO and GAVI, a global vaccine alliance, a COVAX document published on Thursday said. COVAX aims to distribute at least 2 billion effective shots around the world by the end of next year.
The scheme could foot the bill for 92 low-income countries, mostly in Africa and South-East Asia, meaning their governments would face little or no costs from claims brought by patients, should anything go unexpectedly wrong after a COVAX-distributed vaccine is administered.
Indian outfit wins UN award for efforts to combat climate change amid COVID-19
COVID-19 has altered lives, economies and the nature of business on every continent — from the largest cities to the smallest villages. It is the most urgent threat facing humanity today, but we cannot forget that climate change is the biggest threat facing humanity over the long term,UN Climate Change Executive Secretary Patricia Espinosa said
Swiss Re joins global coalition to better predict & prevent outbreak and pandemics, to harness data and analytics
The Trinity Challenge aims to develop ideas and tools for tackling the three stages of infectious disease emergencies – identification, response and recovery.
By becoming a member of The Trinity Challenge, Swiss Re is joining leaders across the academic, non-profit and private sectors including Google, Microsoft and Facebook, GlaxoSmithKline, McKinsey & Company, the Gates Foundation, the University of Cambridge and Imperial College London.
India’s high use of antigen tests risks underestimating COVID-19 spread, says diagnostician
As a consequence of the reduced accuracy, India’s high use of antigen tests compared with a global use of around 10%, risked underestimating the spread of coronavirus, according to Arokiaswamy Velumani, founder of Thyrocare Technologies Ltd, one of India’s top-three diagnostic chains.
India”s COVID-19 caseload crosses 80 lakh
he Union Health Ministry data updated at Wednesday 8 am showed a single-day increase of 43,893 infections, taking the country”s COVID-19 tally of cases to 79,90,322, while the death toll climbed to 1,20,010 with 508 people succumbing to the disease during the same period.
UK Vaccine Taskforce Chair says early COVID-19 vaccines may be imperfect – The Lancet
“However, we do not know that we will ever have a vaccine at all. It is important to guard against complacency and over-optimism”, UK Vaccine Taskforce Chair Kate Bingham wrote in a piece published in The Lancet medical journal.
“The first generation of vaccines is likely to be imperfect, and we should be prepared that they might not prevent infection but rather reduce symptoms, and, even then, might not work for everyone or for long,” she added.
Novartis upbeat as drugmakers see hospitals coping with COVID
ZURICH: Novartis joined rivals Merck, Johnson & Johnson and Roche in predicting the worst of the pandemic may be over for drugmakers, amid signs healthcare systems have learned how to cope with surging infections without shutting down all services. The Swiss...